Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Oragenics Inc

+ Add to Watchlist

UAV:GR

1.010 EUR 0.060 6.32%

As of 14:22:02 ET on 03/27/2015.

Snapshot for Oragenics Inc (UAV)

Open: 0.950 Day's Range: 0.950 - 1.018 Volume: 0
Previous Close: 0.950 52wk Range: 0.564 - 2.164 1-Yr Rtn: -55.07%

Stock Chart for UAV

No chart data available.
  • UAV:GR 1.010
  • 1D
  • 1M
  • 1Y
0.950
Interactive UAV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UAV

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -
Est. PEG Ratio -
Market Cap (M EUR) 36.54
Shares Outstanding (M) 36.18
30 Day Average Volume 118
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UAV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for UAV

Oragenics, Inc. is a biotechnology research and development company seeking to commercialize technologies based on different strains of bacterias. The Company's technologies include a replacement therapy for tooth cavity protection and a new broad-spectrum antibiotic.

Michael O Sullivan "Mike"CFO/Treasurer/SecretaryMartin HandfieldSenior VP:Discovery Research
More Company Profile & Key Executives for UAV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil